It is a chemicals and materials private limited company based in Rajahmundry, Andhra Pradesh, India, established in 2020.
2020 | Rajahmundry, Andhra Pradesh, India | ActiveSsd Pharmaceuticals Private Limited, a active private limited company, was established on 18 February 2020 in Rajahmundry, Andhra Pradesh, India. Engaging in dyes & pigments within the chemicals and materials sector, it holds CIN: U24110AP2020PTC114207. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Chandrasekhar Bejjipuram (Director), Pavan Krishna Akula (Director). Past directors included Sathish, Swarna Deepthi Jami, Siva Satyanarayana Rao Bairi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 36-6-10/1, Market Street, Innespeta, Rajahmundry, Andhra Pradesh, 533101.
U24110AP2020PTC114207
114207
18 February 2020
₹1.00 M
₹0.10 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Ssd Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandrasekhar Bejjipuram | Director | 31 Jul 2021 | Current |
| Pavan Krishna Akula | Director | 16 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Jul 2021 | Past |
| Pramod Abcsdd | Director | 31 Jul 2021 | Past |
| Pramod Abcsdd | Director | 16 Jun 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Ssd Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ssd Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ssd Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ssd Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ssd Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Pavan Krishna Akula was appointed as a Director was appointed as a Director on 16 Jun 2025 & has been associated with this company since 6 months 11 days . was completed.
The activity Ssd Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Ssd Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was documented.
Progress on Chandrasekhar Bejjipuram was appointed as a Director was appointed as a Director on 31 Jul 2021 & has been associated with this company since 4 years 4 months . was documented.
Progress on Ssd Pharmaceuticals Private Limited was registered on 18 Feb 2020 with Roc Vijayawada & aged 5 years 10 months as per MCA records. was documented.
The CIN of Ssd Pharmaceuticals Private Limited is U24110AP2020PTC114207.
Ssd Pharmaceuticals Private Limited is headquartered at 36-6-10/1, Market Street, Innespeta, Rajahmundry, Andhra Pradesh, 533101.
Ssd Pharmaceuticals Private Limited was incorporated on 18 February 2020.
The current directors of Ssd Pharmaceuticals Private Limited are
The primary industry of Ssd Pharmaceuticals Private Limited is Chemicals And Materials.
Ssd Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ssd Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX